References
- Dodick DW. Acute and prophylactic management of migraine. Clin Cornerstone 2001;4:36–52
- Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert Opin Invest Drugs 2001;10:1831–45
- Silberstein SD. Migraine. Lancet 2004;363:381–914.
- Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000;60:1259–87
- Jhee SS, Shiovitz T, Crawford AW, Cutler NR. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clin Pharmacokinet 2001;40:189–205
- Rapoport AM, Tepper SJ. Triptans are all different. Arch Neurol 2001;58:1479–80
- Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001;358:1668–75
- Diener HC, Gendolla A, Gebert I, Beneke M. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Headache 2005;45:874–82
- Mathew NT, Kailasam J, Gentry P, Chernyshev O. Treatment of non-responders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial. Headache 2000;40:464–5
- Stark S, Spierings EL, McNeal S, et al. Naratriptan efficacy in migraineurs who respond poorly to oral sumatriptan. Headache 2000;40:513–20
- Farkkila M, Olesen J, Dahlof C, et al. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan. Cephalalgia 2003;23:463–71
- Dodick DW. Triptan nonresponder studies: implications for clinical practice. Headache 2005;45:156–62
- Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(Suppl 7):1–96
- Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999;39(Suppl 2):S20–S26
- Tfelt-Hansen P, Block G, Dahlof C, et al. Guidelines for controlled trials of drugs in migraine [2nd ed.]. Cephalalgia 2000;20: 765–86
- Whitaker JN. Triptans for migraine headache: therapeutic progress meets a heterogeneous patient response. Arch Neurol 2001;58:1482–3
- Meckling SK, Becker WJ, Rose MS, Dalby JT. Sumatriptan responsiveness and clinical, psychiatric and psychologic features in migraine patients. Can J Neurol Sci 2001;28:313–8
- Dahlof CG, Lipton RB, McCarroll KA, et al. Within-patient consistency of response of rizatriptan for treating migraine. Neurology 2000;55:1511–6
- Goadsby PJ. Serotonin receptors and the acute attack of migraine. Clin Neurosci 1998;5:18–23